Navigation Links
Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation
Date:11/11/2013

New York, New York (PRWEB) November 11, 2013

Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) filed on behalf of individuals who suffered serious instances of internal bleeding, allegedly due to Pradaxa, continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order issued on November 4th, the Court has established a protocol for the selection of bellwether cases in the Pradaxa bleeding litigation. Among other things, the Order directs the parties to each select up to three individual Pradaxa lawsuits as possible bellwether cases, and submit their selections to the Court on December 15th at 5:00 p.m. By January 23, 2014, the Court will select four of those cases for the litigation’s first bellwether trials. Those trials are scheduled to begin in August 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“The selection of bellwether trials will mark an important milestone in the Pradaxa bleeding litigation. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding side effects.

Pradaxa Lawsuits
According to court documents, at least 1,767 Pradaxa lawsuits are now pending in the litigation underway in the Southern District of Illinois. Plaintiffs allege that Boehringer Ingelheim failed to provide adequate warnings to doctors and patients regarding the lack of a readily available antidote to reverse Pradaxa bleeding.

In October, the Institute for Safe Medicine Practices (ISMP) reported that the U.S. Food & Drug Administration (FDA) had tall
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
2. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
3. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
4. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
5. Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar
6. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
7. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
8. Pradaxa Bleeding Lawsuits Help: Resource4thePeople Reports another Medical Research Study Finds Increased Bleeding Risks
9. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
10. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
11. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... 30, 2015 , ... Red Hot & Blue Restaurants, Inc. took ... http://scoutology.com/novaburgerwars and was selected as “Best BBQ” in a Texas-based Living ... Hot & Blue President Randy McCann said, “Everyone knows Red Hot & Blue serves ...
(Date:6/30/2015)... ... June 30, 2015 , ... After more than ... Food and Drug Administration, GlobalSun (TM) — sunscreen specifically formulated for the unique skin ... rating of 35, hits the market just in time to help protect the skin ...
(Date:6/30/2015)... ... 30, 2015 , ... James C. Wittig, MD , ... HackensackUMC and Director of the Skin and Sarcoma division at the John Theurer ... Orthopedic Oncology and Pathology Course. The newly installed lectures are designed to ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... alleging heart attack and stroke incidents are linked to testosterone replacement therapy announce ... Management Conference is scheduled for July 9, 2015, according to court documents.* The ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... announced today a partnership with Knockout Zone Miami (KO Zone), a ... and conditioning specialist and CrossFit Coach, Diego de Vera. The partnership will provide ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3
... honor of World TB Day 2008 (March 24), the ... Medicine Association (HIVMA) are urging U.S. policymakers to step ... against the disease both at home and abroad. , ... progress in detecting new cases on the decline, resources ...
... wearers are often warned to properly clean their lenses ... intense pain, and sight impairment. , Researchers from University ... School of Medicine have been awarded a $2.4 million ... (NEI) to study corneal infection (keratitis) brought on by ...
... At a conference with,security analysts today, DuPont ... Chief,Financial Officer Jeffrey L. Keefer reviewed the company,s ... growth rate over,the next three years., "As ... product innovation," Keefer said. "Our rising return from ...
... Bureau of TennCare and,Shared Health, Tennessee,s largest ... pilot program to introduce ePrescribing,capabilities to rural ... The ePrescribing program is a community approach ... patient care. Fifty rural,physician practices across 13 ...
... and wellness a priority at all,levels, staffing, products, ... 20 Blue Cross and Blue Shield,of Illinois ... spanning all aspects of the company,s business and ... health and wellness,of our members and our communities ...
... March 20 Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ... Amended and Restated Convertible Promissory Note Purchase Agreement,dated ... Gipson, Thomas Gipson, Arthur,Koenig, Ingalls & Snyder Value ... The agreement provides for the Company to borrow,in ...
Cached Medicine News:Health News:ID, HIV experts urge more resources for TB 2Health News:$2.4 million grant for study of corneal infections associated with contact lenses 2Health News:DuPont Chief Financial Officer Reviews Company's Accelerated Growth Plan 2Health News:TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians 2Health News:TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians 3Health News:Blue Cross and Blue Shield of Illinois Evolves its Role, Commits to Health and Wellness of Members and Communities 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 3
(Date:6/30/2015)... LONDON , June 30, 2015 ... Street issued a survey to Rosacea sufferers as part of ... what treatments Rosacea sufferers found effective for their Rosacea. The ... age, and comprised 47% men and 53% women. ... of survey participants did not consider or attempt to visit ...
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015  Avanir Pharmaceuticals, Inc. today ... showing that treatment with NUEDEXTA ® was ... of pseudobulbar affect (PBA) in patients with traumatic ... distressing condition characterized by sudden and uncontrollable outbursts ... diseases or brain injury. PRISM II is a ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... Top-line Data Expected in August -, EXTON, ... today the completion of the pivotal efficacy portion ... Isolagen,Therapy(TM) for the treatment of nasolabial folds, or ... the primary efficacy follow-up visit,and collation of this ...
... ... Professionals, VOORHEES, N.J., July 1 ... a wide spectrum of,severity, ranging from mild diarrhea to pseudomembranous colitis ... who develop an initial,case of CDI.(1) These patients are at increased ...
Cached Medicine Technology:Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: